Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab

  1. Arpín, E.C.
  2. Sobrino, T.G.
  3. Vivero, C.D.
  4. del Campo Amigo Jorrín, M.
  5. Regal, A.R.
  6. González, J.P.
  7. Bouzas, M.L.
Journal:
Neurodegenerative disease management

ISSN: 1758-2032

Year of publication: 2016

Volume: 6

Issue: 1

Pages: 5-12

Type: Article

DOI: 10.2217/NMT.15.53 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus